CGP-51901

N/A

Report date: 2022/03/17 10:19:24

Base Information

Drug NameCGP-51901
Drug Alias NameAntiallergy MAbCGP-51901AL-901
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionImmunoglobulin E inhibitors
TargetsImmunoglobulin E
Therapy Area/IndicationsRhinitis, Allergic, SeasonalAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTanox Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTanox IncNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, SeasonalAsthma

Other Information

ATC CodeN/A
Related LinksN/A